S1PR1 and myeloid sarcoma: In the rodent model of MS, experimental autoimmune encephalomyelitis (EAE), conditional null mouse mutants lacking S1P1 on GFAP-expressing astrocytes but not on neurons showed attenuation of both EAE disease and FTY720-P efficacy (Choi et al. 2011).